Petlife Pharmaceuticals, Inc.
OTC: PTLF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Sebastian Serrell-Watts
- Employees
- 1
- Headquarters
- Los Angeles, United States
- IPO year
- 2008
- Market cap
- $19.7K
- Website
- https://www.petlifepharma.com
Loading PTLF…
Loading profile data…Frequently asked questions about PTLF
What does Petlife Pharmaceuticals, Inc. (PTLF) do?
Based in Los Angeles, California, Petlife Pharmaceuticals, Inc. is dedicated to the discovery, formulation, commercialization, and ongoing support of both medicinal drugs and nutritional supplements for pets. Their primary focus is on addressing canine and feline cancer and various autoimmune conditions, such as arthritis, within the United Stat...
Where does PTLF trade?
Petlife Pharmaceuticals, Inc. (PTLF) trades on the Other OTC.
What sector is PTLF in?
Petlife Pharmaceuticals, Inc. (PTLF) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Petlife Pharmaceuticals, Inc.?
Sebastian Serrell-Watts is the chief executive officer of Petlife Pharmaceuticals, Inc. (PTLF).
Where is Petlife Pharmaceuticals, Inc. headquartered?
Petlife Pharmaceuticals, Inc. is headquartered in United States.
Does PTLF pay a dividend?
Petlife Pharmaceuticals, Inc. (PTLF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did PTLF go public?
Petlife Pharmaceuticals, Inc. (PTLF) completed its initial public offering in 2008.